News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yan Leyfman: Can bendamustine replace Flu/Cy as lymphodepleting chemotherapy before CAR-T in relapsed/refractory NHL
Yan Leyfman
Jun 17, 2025, 23:49

Yan Leyfman: Can bendamustine replace Flu/Cy as lymphodepleting chemotherapy before CAR-T in relapsed/refractory NHL

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“New Study Alert: CAR-T Prep Reimagined! Can bendamustine replace Flu/Cy as lymphodepleting chemotherapy before CAR-T in relapsed/refractory NHL?
In a large real-world study (n=265), bendamustine showed:
  •  Comparable OS and PFS
  •  Less severe neutropenia (71% vs. 17%)
  •  Greater feasibility in outpatient settings
A promising alternative amidst global fludarabine shortages. Time to rethink how we prep for CART therapy? Kaplan-Meier and Cox models adjusted for CAR-T product, year, subtype, and steroid use.”

Title: Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma

Authors: Uttam K. Rao, Navneet S. Majhail, Betsy Blunk, Karin Abernathy, Carlos Bachier, Vikas Bhushan, Jose Carlos Cruz, Mohammed Elayan, Tara Gregory, Charles F. LeMaistre, Shahbaz A. Malik, Casey Martin, Meredith Mattlin, Gabrielle Blade, Michael B. Maris, John Mathews, Luke Mountjoy, Jeremy M. Pantin, Aravind Ramakrishnan, Paul Shaughnessy, Minoo Battiwalla

Read the Full Article.

Yan Leyfman

More posts featuring Yan Leyfman.

Aravind Ramakrishnan Betsy Blunk cancer Carlos Bachier Casey Martin Charles F. LeMaistre Gabrielle Blade Jeremy M. Pantin John Mathews Jose Carlos Cruz Karin Abernathy Luke Mountjoy Meredith Mattlin Michael B. Maris Minoo Battiwalla Mohammed Elayan Navneet S. Majhail OncoDaily Oncology Paul Shaughnessy Shahbaz A. Malik Tara Gregory Uttam K. Rao Vikas Bhushan
Special Coverage
Blog
Jul 9, 2025, 17:36
Wafaa M Rashed: Ethics, Equity and Policy - Through the Eyes of a Future Leader
Blog
Jul 9, 2025, 17:21
Bernard Fox: What Do Cancer Researchers Need Today?
Blog
Jul 9, 2025, 17:21
Wafik S. El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development
Blog
Jul 9, 2025, 17:19
David Skorton: AAMC Viewpoint on a Fourth-Year Medical Student Who Responded to an In-Flight Medical Emergency
Blog
Jul 9, 2025, 17:11
Oliver Bogler: Essential Steps for Your Research Proposal
Blog
Jul 9, 2025, 17:09
GENIAL is Paving the Way for More Effective, Personalized Care
Blog
Jul 9, 2025, 16:58
Graham Collins: TRANSFORM Study - Liso-Cel vs Standard 2nd Line in 1st Relapse Large B-Cell NHL
Blog
Jul 9, 2025, 16:50
David Zaas: Hugh Chatham Health has Joined Atrium Health Wake Forest Baptist
Blog
Jul 9, 2025, 16:48
Aman Chauhan Highlights NANETS Abstract Submission Deadline and Upcoming NCAN NET Patient Conference
Science
Jul 9, 2025, 16:44
Nicolas Duployez: The Genomic Landscape of AML
Blog
Jul 9, 2025, 16:36
MASCC 2025 Meeting Abstracts Are Now Available
Blog
Jul 9, 2025, 16:35
The Physics Behind Precision - Professor Steve Webb and the Evolution of Radiotherapy - The Institute of Cancer Research